We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks. In this piece, we ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

Like its English-language predecessor, which launched in 2016, this Spanish-language patient community from MyHealthTeam is ...

In a year that has seen an approval and a raft of readouts for metabolic dysfunction-associated steatohepatitis (MASH), ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Gilead Sciences (GILD) reachead $85.83 at the closing of the latest trading day, reflecting a +0.91% change compared to its last close.

It is an exciting time at Adverum as we progress toward the initiation of Ixo-vec’s pivotal program in the first half of 2025,” stated Laurent Fischer, M.D., president and chief executive officer of ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

The fans voted him the winner of the Marion Star Football Player of Week 8 Poll due to his production. He earned 926 of 2,566 votes (36 percent) to take the honor. More on RV's receivers: Week 9 ...

On Friday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.95 which represents a slight increase of $0.28 or 0.33% from the prior close of $84.67. The stock opened at $84 ...

Lydia Price of Marion Harding won the MOAC girls cross country championship with a time of 18:40. Brogan Weston of Ridgedale ...

Shares of Gilead Sciences Inc. GILD inched 0.33% higher to $84.95 Friday, on what proved to be an all-around great trading ...